Randomized cinical trial with a inulin enriched cookie on cardiovascular risk factor in obese patients;Ensayo clínico aleatorizado con una galleta enriquecida en inulina en el patrón de riesgo cardiovascular de pacientes obesos

Nutricion Hospitalaria

Volumn 25, Issue 1, 2010, Pages 53-59

  De Luis, D A ^a   De La Fuente, B ^a   Izaola, O ^a   Conde, R ^a   Gutierrez S ^b   Morillo, M ^c   Teba Torres, C ^c  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b División de Investigación Gullón S A

^c Centro de Automatización Robótica   (Spain)

Author keywords

Cardiovascular risk factors; Cookies; Inulin; Obesity

Indexed keywords

INULIN; LIPID;

ADULT; AGED; ARTICLE; BLOOD; BODY WEIGHT; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DIETARY FIBER; FEMALE; HUMAN; MALE; MIDDLE AGED; OBESITY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADULT; AGED; BODY WEIGHT; CARDIOVASCULAR DISEASES; DIETARY FIBER; FEMALE; HUMANS; INULIN; LIPIDS; MALE; MIDDLE AGED; OBESITY; RISK FACTORS;

EID: 76449115438     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2010.25.1.4535     Document Type: Article

References (24)

1. Aranceta-Bartrina J, Serra-Majem L, Foz-Sala M, Moreno- Esteban B; Grupo Colaborativo SEEDO. Prevalence of obesity in Spain. Med Clin (Barc) 2005; 125 (12): 460-466.
2. De Luis DA, Aller R, González Sagrado M, Izaola O, Conde R. The effects of a low fat versus a low carbohydrate diet on adipocytokines in obese adults. Hormone Research 2007; 67: 296-300.
3. De Luis DA, Pacheco D, Izaola O, Teroba M, Cuellar L, Martin T. Clinical Results and nutritional consequences of biliopancreatic diversion: Three years of follow up. Ann Nutr Metab 2008; 53: 234-238.
4. Romero AL, Romero JE. Cookies enriched with psyllium or oat bran lower plasma LDL cholesterol in normal and hypercholesteronemic men from northern mexico. J of American College of Nutrition 1998; 6: 601-608.
5. Kerkhoffs D, Hornstra G. Cholesterol-lowering effect of beta glucan from oat bran in mildly hypercholeteronemic subjects may decrease when beta glucan s incorporated into bread and cookies. Am J Clin Nutr 2003; 78: 221-227.
6. Keogh G, Cooper G, Mulvey T. Randomized controlled crossover study of the effect of a highly beta glucan enriched barley on cardiovascular disease risk factors in moldly hypercholesterolemic men. Am J Clin Nutr 2003; 78: 711-718.
7. Roberfroid M. Prebiotics: The concept revisited. 1. J Nutr 2007; 137: 830S-837S.
8. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher Df. Homeostasis model assessment: Insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetología 1985; 28: 412-414.
9. Lukaski H, Johson PE. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985; 41: 810-817.
10. Mataix J, Mañas M. Tablas de composición de alimentos españoles. Ed: University of Granada, 2003.
11. Luo J, Rizkalla SW, Alamowitch C y cols. Chronic 23. consumption of short-chain fructooligosaccharides by healthy subjects decreased basal hepatic glucose production but had no effect on insulin-stimulated glucose metabolism. Am J Clin Nutr 1996; 63: 939-945.
12. Van Dokkum W, Wezendonk B, Srikumar TS, 18. Van Den Heuvel EG. Effect of nondigestible oligosaccharides on largebowel functions, blood lipid concentrations and glucose absorption in young healthy male subjects. Eur J Clin Nutr 1999; 53: 1-7.
13. Olesen M, Gudmand-Hoyer E. Efficacy, safety, and 38. tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome. Am J Clin Nutr 2000; 72: 1570-1575.
14. Letexier D, Diraison F, Beylot M. Addition of inulin 19. to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans. Am J Clin Nutr 2003; 77: 559-564.
15. Balcazar-Munoz BR, Martínez-Abundis 42. E, González-Ortiz M. Effect of oral inulin administration on lipid profile and insulin sensitivity in subjects with obesity and dyslipidemia. Rev Med Chil 2003; 131: 597-604.
16. Yamashita K, Kawai K, Itakura M. Effects of 25. fructooligosaccharides on blood glucose and serum lipids in diabetic subjects. Nutr Res 1984; 4: 961-966.
17. Giacco R, Clemente G, Luongo D y cols. Effects of 21. shortchain fructo-oligosaccharides on glucose and lipid metabolism in mild hypercholesterolaemic individuals. Clin Nutr 2004; 23: 331-340.
18. Malkki Y. Oat fiber. In Handbook of dietary fiber. Edited bu: Cha SS, Dreher ML, New Cork Macrel Dekker 2001; 497-512.
19. Jenkins DJA, Leeds AR, Gmull MA, Cochet B, Alberti KGMH, Decrease in pstprandial insulin and glucose concentrations by guar and pectin. Ann Int Med 1977; 86: 20-24.
20. Jenkins DJA, Wolever TMS; Ocana AM, Vuksan V. Metabolic effects of reducing rate of glucose ingestion by single bolus versus continuos sipping. Diabetes 1990; 39: 775-780.
21. Wolever TMS, Brighenti F, Jenkins DJA. Serum short Chain fatty acids alter rectal infusion of acetate and propionate in man. J Clin Nutr Gastroenterol 1988; 3: 42-46.
22. López Román J, Martínez Gonzálvez AB, Luque A, Pons Miñano JA, Vargas Acosta A, Iglesias JR, Hernández M, Villegas JA. [The effect of a fibre enriched dietary milk product in chronic primary idiopatic constipation]. Nutr Hosp 2008; 23: 12-19.
23. García Peris P, Velasco Gimeno C. [Evolution in the knowledge on fiber] Nutr Hosp 2007; 22 (Supl. 2): 20-25.
24. Lecumberri E, Mateos R, Ramos S, Alía M, Rúperez P, Goya L, Izquierdo-Pulido M, Bravo L. [Characterization of cocoa fiber and its effect on the antioxidant capacity of serum in rats] Nutr Hosp 2006; 21 (5): 622.